Medscape InDiscussion: Schizophrenia

12 Episodes

1. S2 Episode 6: Is MDMA a Potential Treatment for Negative Symptoms of Schizophrenia? Exploring Stigma and Strategies to Alleviate Symptoms

   Published: 7/20/2023
2. S2 Episode 5: First-Episode Schizophrenia: The Importance of Engaging and Educating Patients and Their Families in Treatment

   Published: 6/21/2023
3. S2 Episode 4: Common and Commonly Unrecognized: Clinical High-risk Syndrome, Psychosis, and Schizophrenia

   Published: 5/23/2023
4. S2 Episode 3: Psychiatric Comorbidity in Schizophrenia: Assessing Patients and the Impact on Treatment Decisions and Outcomes

   Published: 4/19/2023
5. S2 Episode 2: Long-Acting Injectables and Schizophrenia: Mitigating the Risk for Relapse and Rehospitalization

   Published: 3/22/2023
6. S2 Episode 1: Treatment-Resistant Schizophrenia: Detection, Management, and the Importance of Early Initiation of Treatment

   Published: 3/22/2023
7. S1 Episode 6: Relapse in Schizophrenia: Why It Occurs, How Often It Occurs, and What We Can Do About It

   Published: 12/7/2022
8. S1 Episode 5: Neuroimaging in Schizophrenia: What Have We Learned?

   Published: 11/9/2022
9. S1 Episode 4: How Can We Assess Cognitive Functioning in Patients With Schizophrenia? And What Can We Do About It?

   Published: 10/5/2022
10. S1 Episode 3: What New Antipsychotic Drugs Are Available for Schizophrenia? What Drugs Are Under Development? And What Do They Potentially Offer?

    Published: 9/13/2022
11. S1 Episode 2: Antipsychotics in Schizophrenia: Effectiveness and Optimal Dosing

    Published: 8/2/2022
12. S1 Episode 1: What Are the Major Metabolic and Neurologic Risks Associated With Antipsychotic Medications?

    Published: 8/2/2022